Skip to main content
OpenTrials
Completed

NCT Number: NCT02773719

Biofields Therapy on Warts

Traditionally, healers are willing to look after, two out of three French citizens have already appealed to them at least once during their lives. Many healers in good faith are exercising their magnetism as a "gift" often inherited from elders. Now, they create interest of doctors who do not hesitate in some cases to ensure their cooperation, to implicitly recognize their mysterious talents. Some serious studies have examined these practices: Several studies have been conducted on the influence of biofield therapies in pain, depression and fatigue in cancer disease. The investigators propose a study of the effect of magnetism on the wart disease whose cure is objectively assessable.

Sixty-two subjects in total would be included, comparing 2 proportions observed: the proportion of healing in the group treated with a "real" biofield therapist (recognized and affiliated to the National Group for Alternative Medicine in France) to the proportion of healing in the group treated with a "fake" biofield therapist (someone assessed as not having capacity to magnetize). The "fake" biofield therapist, placebo, has been trained to replicate gestures during a training validated by an independent recognized biofield therapist.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Caen University Hospital

Caen, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Patients with common warts on hands or feet for over at least 3 months are eligible for the study. Patients fulfilling one or more of the following criteria will not be included: lack of informed consent prior to randomization, younger than 18 years or under judicial protection, treated with oral corticotherapy for more than 6 months, immunosuppressed or with history of transplant surgery, undergoing chemotherapy or suspected to have carcinomatous warts, or patients with infected warts, injured warts or already treated within 90 days with chemical processing, medical device, surgery or ever treated with biofield therapy.

Subject will be excluded from the study if its warts was treated by other treatment during protocol.

  • ulcerated wart
  • cancerous wart

Treatment and study plan

True Biofield therapy

Other

Fake Biofield therapy

Other

Primary outcomes

  1. disappearance of a common palmar or plantar wart

    Time frame: week 3

Secondary outcomes

  1. disappearance of each other wart than the original one 3 weeks after the therapy

    Time frame: week 3

  2. Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3

    Time frame: week3

  3. Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3

    Time frame: week 3

  4. Disappearance of warts at 6 weeks

    Time frame: week 6

  5. Level of belief in biofield therapy of the subject

    Time frame: week 6

    week 0

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Official study title

Effect of the Intervention of Biofields Therapy on Warts of the Hands and Feet in Adults: a Prospective, Randomized, Double-blind Trial

Acronym: MAGNETIK

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
May 16, 2016
Registry last updated
Apr 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.